Product Description
Nebiroll 5 mg Tablet is a third-generation beta-1 selective adrenergic blocker with additional nitric oxide (NO)-mediated vasodilatory effects. This unique dual mechanism reduces heart rate and myocardial oxygen demand while simultaneously promoting vasodilation and improving arterial compliance. Compared to older beta-blockers, Nebivolol has a more favorable safety profile, causing less fatigue, fewer metabolic side effects, and minimal impact on sexual function. The 5 mg strength is the standard therapeutic dose used in adults for managing hypertension and certain cardiac conditions. By improving endothelial function and reducing oxidative stress, Nebivolol provides additional cardiovascular protection beyond simple blood pressure control, making it especially useful in patients with comorbid conditions such as diabetes or metabolic syndrome.